Rybodyn
Rybodyn is a biotechnology research company that develops therapeutics to train the immune system to detect and eradicate cancer internally.
$10M Seed ·
Source: SynBioBeta
Latest round on record: Seed, July 2026, amount undisclosed.
All 3 rounds ↓Signals
Website registeredFeb 1, 2022 (4 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Seed | undisclosed | — | — | |
| Seed | $10M | — | SynBioBeta |
Timeline
- IndieBio SF 15
IIndieBio · batchSource: indiebio.co - Website created
Founders and team
CD
Corey Dambacher FounderIA
Imad Ajjawi FounderKW
Kerry Wilson Founder
Investors
Companies like Rybodyn
CCirrus Therapeutics$14.7M Seed · Aug 2026
OOuro Medicines$120M Series A · Jan 2025
HHaptena Therapeutics$3.53M Seed · Dec 2025NNormunity$75M Series B+ · Jan 2025
AAltruBio$225M Series B+ · May 2024
MMemo Therapeutics$22M Series B+ · May 2024
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/rybodyn (get a free API key).